Norcross, Ga.-based RayBiotech has launched a partnering program to provide its proteomic analysis services through diagnostic core facilities at academic and government research institutes in the US and Canada.
The company aims to emphasize its Quantibody biomarker quantitation tools, but all of its services, including ELISAs and phosphorylation arrays, will be available through the program.
The initiative is focused on core facilities that emphasize protein biomarker and proteomic analyses in their offerings to researchers, the company said.
The initiative aims "to establish new relationships with cutting-edge cores willing to adapt our platforms into their diagnostic services platforms," said RayBiotech co-founder and chief operating officer Rani Huang.